Systemic Botulism Toxicity Caused by Pyloric Botox Injection to Treat Gastroparesis

Systemic botulism resulting from therapeutic Botox (OnabotulinumtoxinA) injection has been rarely reported, and never in the context of pylorus injection to treat gastroparesis. We report the case of a 27-year-old female with Emery-Dreifuss muscular dystrophy who developed severe systemic botulism t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bensen, Gordon P., Rutherford, Cristina C., Gardner, Timothy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443624/
https://www.ncbi.nlm.nih.gov/pubmed/32884513
http://dx.doi.org/10.1159/000508854
Descripción
Sumario:Systemic botulism resulting from therapeutic Botox (OnabotulinumtoxinA) injection has been rarely reported, and never in the context of pylorus injection to treat gastroparesis. We report the case of a 27-year-old female with Emery-Dreifuss muscular dystrophy who developed severe systemic botulism toxicity following the intrapyloric injection of 100 units of Botox to treat gastroparesis. The patient eventually made a full recovery.

Ejemplares similares